MONTCO.Today on MSN8h
Audubon’s Globus Medical Makes Game-Changing Acquisition
Audubon-based Globus Medical has announced its acquisition of California life sciences company Nevro Corp. for $250 million ...
Redefining healthcare innovation to benefit the whole patient
Pharmaceutical company Takeda is pioneering a technology-enabled, patient-centered future for plasma-derived therapies ...
manilatimes21h
Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.
Bolt Biotherapeutics, Inc., announced today that the target of their worldwide co-development collaboration with Toray Industries, Inc. is Caprin-1, a novel cancer target discovered by Toray. The ...
SpringWorks Therapeutics Announces FDA Approval of GOMEKLIâ„¢ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...